These results indicated that the inhibition of TGFβ signaling in Py2T TBRDN cells was sufficient to prevent a loss of E-cadherin expression and to preserve an epithelial phenotype in some but not all tumor areas. The gene discussed is TGFB1; the disease is neoplasm.